Samsung hints at a game-changing non-invasive blood glucose monitor for a future Galaxy Watch, potentially revolutionizing ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

KeyBanc highlighted WST, GXIG, and STVN as the main beneficiaries following robust demand in the Continuous Glucose Monitoring (CGM) device market, as evidenced by Abbott Laboratories (NYSE:ABT)' ...

With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick. But some parents say it falls to them to keep an eye on blood sugar levels ...

Samsung's non-invasive blood glucose monitor could revolutionize health tracking. Learn more about this groundbreaking technology.

Samsung unveils groundbreaking non-invasive blood glucose monitoring technology for future wearables, potentially ...

Samsung is working on noninvasive blood sugar monitoring tech, which could be a game-changer. But it isn't ready for the ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung ...

Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...

Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...